These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 7533663

  • 1. Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers.
    Vukanovic J, Isaacs JT.
    Cancer Res; 1995 Apr 01; 55(7):1499-504. PubMed ID: 7533663
    [Abstract] [Full Text] [Related]

  • 2. The antiangiogenic agent linomide inhibits tumor necrosis factor-alpha secretion via inhibition of its synthesis.
    Joseph IB, Isaacs JT.
    Prostate; 1996 Sep 01; 29(3):183-90. PubMed ID: 8827087
    [Abstract] [Full Text] [Related]

  • 3. The antitumor effects of the quinoline-3-carboxamide linomide on Dunning R-3327 rat prostatic cancers.
    Ichikawa T, Lamb JC, Christensson PI, Hartley-Asp B, Isaacs JT.
    Cancer Res; 1992 Jun 01; 52(11):3022-8. PubMed ID: 1591718
    [Abstract] [Full Text] [Related]

  • 4. Human prostatic cancer cells are sensitive to programmed (apoptotic) death induced by the antiangiogenic agent linomide.
    Vukanovic J, Isaacs JT.
    Cancer Res; 1995 Aug 15; 55(16):3517-20. PubMed ID: 7543015
    [Abstract] [Full Text] [Related]

  • 5. Antiangiogenic treatment with linomide as chemoprevention for prostate, seminal vesicle, and breast carcinogenesis in rodents.
    Joseph IB, Vukanovic J, Isaacs JT.
    Cancer Res; 1996 Aug 01; 56(15):3404-8. PubMed ID: 8758902
    [Abstract] [Full Text] [Related]

  • 6. Antiangiogenic effects of the quinoline-3-carboxamide linomide.
    Vukanovic J, Passaniti A, Hirata T, Traystman RJ, Hartley-Asp B, Isaacs JT.
    Cancer Res; 1993 Apr 15; 53(8):1833-7. PubMed ID: 7682157
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
    Joseph IB, Isaacs JT.
    Cancer Res; 1997 Mar 15; 57(6):1054-7. PubMed ID: 9067270
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of angiogenesis and metastases of the Lewis-lung cell carcinoma by the quinoline-3-carboxamide, Linomide.
    Borgström P, Torres Filho IP, Hartley-Asp B.
    Anticancer Res; 1995 Mar 15; 15(3):719-28. PubMed ID: 7544090
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents.
    Joseph IB, Isaacs JT.
    J Natl Cancer Inst; 1998 Nov 04; 90(21):1648-53. PubMed ID: 9811314
    [Abstract] [Full Text] [Related]

  • 12. Multiformic modulation of endotoxin effects by linomide.
    Shalev M, Ko A, Gelderman MP, Fortin E, Reed G, Slavin S, Gery I.
    Clin Immunol; 1999 Dec 04; 93(3):250-5. PubMed ID: 10600336
    [Abstract] [Full Text] [Related]

  • 13. Negative regulators of in vivo erythropoiesis: interaction of IL-1 alpha and TNF-alpha and the lack of a strict requirement for T or NK cells for their activity.
    Johnson CS, Pourbohloul SC, Furmanski P.
    Exp Hematol; 1991 Feb 04; 19(2):101-5. PubMed ID: 1991491
    [Abstract] [Full Text] [Related]

  • 14. Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer.
    Isaacs JT, Pili R, Qian DZ, Dalrymple SL, Garrison JB, Kyprianou N, Björk A, Olsson A, Leanderson T.
    Prostate; 2006 Dec 01; 66(16):1768-78. PubMed ID: 16955399
    [Abstract] [Full Text] [Related]

  • 15. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
    Dahlberg PS, Acton RD, Battafarano RJ, Uknis ME, Ratz CA, Johnston JW, Haseman JR, Gray BH, Dunn DL.
    J Surg Res; 1996 Jun 01; 63(1):44-8. PubMed ID: 8661170
    [Abstract] [Full Text] [Related]

  • 16. (+)-Catechin inhibits tumour angiogenesis and regulates the production of nitric oxide and TNF-alpha in LPS-stimulated macrophages.
    Guruvayoorappan C, Kuttan G.
    Innate Immun; 2008 Jun 01; 14(3):160-74. PubMed ID: 18562575
    [Abstract] [Full Text] [Related]

  • 17. Intravenous immunoglobulin modulates human mononuclear phagocyte tumor necrosis factor-alpha production in vitro.
    Darville T, Tabor D, Simpson K, Jacobs RF.
    Pediatr Res; 1994 Apr 01; 35(4 Pt 1):397-403. PubMed ID: 8047375
    [Abstract] [Full Text] [Related]

  • 18. Thrombin enhances monocyte secretion of tumor necrosis factor and interleukin-1 beta by two distinct mechanisms.
    Hoffman M, Cooper ST.
    Blood Cells Mol Dis; 1995 Apr 01; 21(2):156-67. PubMed ID: 8846045
    [Abstract] [Full Text] [Related]

  • 19. Effect of alcohol on the secretion of tumor necrosis factor-alpha by macrophages in the presence of rat serum.
    Nakatani Y, Fukui H, Kitazawa T, Fujimoto M, Yamao J, Uemura M.
    Alcohol Clin Exp Res; 2002 Aug 01; 26(8 Suppl):81S-85S. PubMed ID: 12198381
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.